Prostate Surgery Linked to Cancer Deaths
A terse report notes deaths tied to prostate cancer after surgery. Data include mortality rate estimates and related survival figures, highlighting risks of treatment and the need for careful patient counseling.
Prostate surgery shown to save lives for men under 65
A landmark study indicates that prostate cancer surgery halves death risk for men under 65, while results for those over 65 remain uncertain. The Swedish led trial followed 695 men across 14 hospitals for a decade, comparing surgery with watchful waiting.
MENTIONED IN THIS ARTICLE
Dorado Brooks
American Cancer Society
United States
The
Cancer Society
New England Journal of Medicine
Anna Bill-Axelson
University Hospital
Uppsala
Sweden
Patrick Walsh
Johns Hopkins Medical
Finland
Iceland
Vaccine supply and demand haunt flu meeting in Chicago
Public health officials and manufacturers convened for a two day session in Chicago to curb a potential flu shot shortage. Only one maker is licensed for the upcoming season while two others including Chiron Corp are making progress toward entering the market. Concerns center on underproduction, past shortages, and the need to protect the at risk 180 million population with a target of 90 million annual shots by August. Chiron aims for 25 to 30 million pending FDA approval and Sanofi Pasteur reports pre orders and waiting lists as production yet to begin.
MENTIONED IN THIS ARTICLE
Chicago
United States
Chiron Corp
Liverpool
England
Nancy Bennett
Monroe County Department of Public Health
Rochester
Federal
Centers For Disease Control and Prevention
American Medical Association
U.S
CDC
Stephen Cochi
Chiron
Food and Drug Administration
Peter Galiano
Sanofi Pasteur
Also Mentioned on This Page
New England
By Linpa A. Johnson
Associated Press
Lowe’s
LowesForPros.com
Owens Corning
Oakridge
Mer
Lowes.com